Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Everglades |
Description | Home Our Company Additional Resurces Publications Contact Everglades Biopharma is a leader in developing ligand-based therapies. A proprietary technology |
Keywords | N/A |
WebSite | evergladesbiopharma.com |
Host IP | 192.254.186.158 |
Location | United States |
Site | Rank |
US$830
Last updated: 2023-05-08 03:13:42
evergladesbiopharma.com has Semrush global rank of 0. evergladesbiopharma.com has an estimated worth of US$ 830, based on its estimated Ads revenue. evergladesbiopharma.com receives approximately 95 unique visitors each day. Its web server is located in United States, with IP address 192.254.186.158. According to SiteAdvisor, evergladesbiopharma.com is safe to visit. |
Purchase/Sale Value | US$830 |
Daily Ads Revenue | US$0 |
Monthly Ads Revenue | US$23 |
Yearly Ads Revenue | US$276 |
Daily Unique Visitors | 6 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
evergladesbiopharma.com. 7199 | A | evergladesbiopharma.com. 7199 | IP: 192.254.186.158 |
evergladesbiopharma.com. 86400 | NS | evergladesbiopharma.com. 86400 | NS Record: ns6337.hostgator.com. |
evergladesbiopharma.com. 86400 | NS | evergladesbiopharma.com. 86400 | NS Record: ns6338.hostgator.com. |
evergladesbiopharma.com. 14400 | MX | evergladesbiopharma.com. 14400 | MX Record: 0 mail.evergladesbiopharma.com. |
evergladesbiopharma.com. 14400 | TXT | evergladesbiopharma.com. 14400 | TXT Record: v=spf1 a mx include:websitewelcome.com ~all |
Home Our Company Additional Resurces Publications Contact Everglades Biopharma is a leader in developing ligand-based therapies. A proprietary technology of ligandomics enables systematic identification of disease-specific cellular ligands as therapeutic targets. Therapies can be rationally developed by overexpressing beneficial ligands or blocking detrimental ligands. Therapies against disease-specific ligands is expected to have higher therapeutic efficacy and less side effects than against non-disease-specific ligands. A leading product of the Company is a therapeutic antibody against a novel angiogenic ligand that is upregulated in neovascular disease conditions but not expressed in normal vessels. This antibody drug is under development for the therapy of neovascular age-related macular degeneration (AMD), diabetic macular edema and cancer. © Copyright Everglades Biopharma. All rights |
HTTP/1.1 200 OK Date: Fri, 29 Oct 2021 05:56:20 GMT Server: Apache Upgrade: h2,h2c Connection: Upgrade Last-Modified: Sun, 28 Jan 2018 00:12:27 GMT Accept-Ranges: bytes Content-Length: 3434 Vary: Accept-Encoding Content-Type: text/html |
Domain Name: EVERGLADESBIOPHARMA.COM Registry Domain ID: 1982588651_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2019-09-29T21:35:53Z Creation Date: 2015-11-20T14:45:15Z Registry Expiry Date: 2021-11-20T14:45:15Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS6337.HOSTGATOR.COM Name Server: NS6338.HOSTGATOR.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T20:21:37Z <<< |